Streetbeat News

COCH

Envoy Medical, Inc.

https://www.envoymedical.com

Industry

Medical - Devices

Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include hearing aids; Esteem middle ear implants; bone conduction devices; and Acclaim cochlear implants. Envoy Medical Corporation was formerly known as St. Croix Medical, Inc. and changed its name to Envoy Medical Corporation in December 2004. The company was founded in 1995 and is based in White Bear Lake, Minnesota.

Open

2.05

Mkt cap

40M

Volume

50K

High

2.10

P/E Ratio

-1.53

52-wk high

11.46

Low

1.90

Div yield

N/A

52-wk low

1.08

Envoy Medical, Inc. (NASDAQ: COCH) has announced the selection of seven investigational sites for its pivotal clinical trial of the Acclaim cochlear implant, with patient enrollment expected in Q1 2025.

Portfolio Pulse from

December 19, 2024 | 2:15 pm

In Friday's after-market session, several healthcare stocks experienced significant price movements. Nuwellis (NUWE) saw a remarkable increase of 106.6%, while Purple Biotech (PPBT) and others also gained. Conversely, Psyence Biomedical (PBM) and Venus Concept (VERO) were among the notable decliners.

Portfolio Pulse from Benzinga Insights

November 01, 2024 | 8:36 pm

In Friday's pre-market session, several healthcare stocks experienced significant movements. Envoy Medical, Theriva Biologics, and Athira Pharma saw notable gains, while Lexicon Pharmaceuticals and others faced declines. Earnings reports influenced some stock movements.

Portfolio Pulse from Benzinga Insights

November 01, 2024 | 12:12 pm

Portfolio Pulse from Benzinga Insights

November 01, 2024 | 12:11 pm

Envoy Medical's stock is rising following FDA approval for its Investigational Device Exemption application, allowing a pivotal study of the Acclaim Fully Implanted Cochlear Implant.